Sarepta Therapeutics Balance Sheet - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$42.54 $1.41 (3.21%) SRPT stock closing price Jul 25, 2017 (Closing)

The fundamental analysis of this company requires a thorough look at Sarepta Therapeutics balance sheet. As in our Sarepta Therapeutics stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The Sarepta Therapeutics balance sheet for 2017-Q1 shows cash on hand of $274.72M. The cash has increased by $152.3M. Sarepta Therapeutics revenue was $35.01M and Sarepta Therapeutics operating cash flow was $-57.88M. View Sarepta Therapeutics quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Marketable Securities115.59M206.12M10.69M101.85M122.88M44.09M87.34M91.78M136.79M187.71M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets24.27M26.89M22M16.88M17.38M19.46M23.09M24.41M35.03M26.43M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment69.9M68.14M64.04M62.8M61.93M60.74M59.38M58.79M58.39M56.04M
Accumulated Depreciation31.48M30.34M28.42M25.82M24.59M23.36M22.19M21.03M19.89M18.86M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M0.78M0.78M11.47M0.78M0.78M0.78M0.64M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets7.34M3.96M8.05M8.14M4.47M7.67M5.31M5.27M2.06M5.72M
Sarepta Therapeutics Total Assets
Notes Payable-2.49M2.49M-------
Accounts Payable27.44M29.69M20.68M18.67M20.23M7.43M14.09M9.31M12.4M0.96M
Current Portion Long-Term Debt11.34M10.1M10.1M7.6M5.93M3.43M0.1M0.09M0.09M0.09M
Current Portion Capital Leases----------
Accrued Expenses31.15M31.01M29.53M24.27M29.05M19.76M15.18M15.03M17.36M14.82M
Income Taxes Payable----------
Other Current Liabilities4.68M4.6M4.6M4.6M4.57M4.58M4.67M4.61M4.5M4.42M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.41M5.94M5.26M5.86M6.17M6.45M6.72M6.59M6.77M6.36M
Convertible Debt----------
Long-Term Debt2.34M6.04M8.49M13.37M14.96M17.39M20.65M1.45M3.73M3.76M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M0.01M0.01M-----
Capital Surplus1.51B1.5B1.49B1.1B1.09B957.6M947.82M941.35M926.76M920.86M
Retained Earnings-1.08B-1.17B-1.08B-958.82M-899.05M-834.37M-782.43M-740.58M-679.02M-634.6M
Treasury Stock----------
Other Liabilities-0.05M-0.12M--0.01M-0.11M--0.01M-0.01M-0.09M-0.05M
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Most investors just check the Sarepta Therapeutics stock price, and Sarepta Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Sarepta Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: Anything that the Sarepta Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Sarepta Therapeutics had total assets of $511.53M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Sarepta Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SRPT stock stand at $82.39M.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover

Quarterly Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, DBV Tech balance sheet, Gilead Sciences balance sheet, Kythera Biopharma balance sheet